GENETIC DETERMINANTS OF AUTOIMMUNE ARTHRITIS: AN IMMUNOGENETIC APPROACH

Abstract

Autoimmune arthritis is a complex inflammatory disorder shaped by the interplay of genetic susceptibility, immune dysregulation, and clinical phenotype variability. This study employed a mixed-methods immunogenetic framework to examine the influence of high-risk single nucleotide polymorphisms (SNPs), HLA class I and II allelic variations, cytokine activation profiles, and T-cell signaling markers on disease severity and progression. Genomic screening revealed distinct clusters of risk-associated SNPs and HLA variants strongly correlated with heightened inflammatory responses. Cytokine profiling demonstrated consistently elevated IL-6, TNF-α, IL-17, and IFN-γ levels among genetically predisposed individuals, supporting the mechanistic link between genetic architecture and amplified immune activation. Phenotypic assessments further identified heterogeneous disease trajectories, with genetically high-risk patients exhibiting more frequent flares, aggressive symptom progression, and greater functional impairment. The integration of genomic, immunological, and clinical datasets into an immunogenetic risk index provided enhanced predictive accuracy for disease activity compared with traditional single-parameter assessments. These findings emphasize that autoimmune arthritis comprises multiple molecularly distinct subtypes rather than a single uniform condition, underscoring the importance of individualized diagnostic and therapeutic strategies. The study concludes that early immunogenetic screening and cytokine monitoring can improve clinical decision-making, support precision-based treatment planning, and ultimately contribute to better long-term outcomes for patients with autoimmune arthritis.